{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T19:56:49Z","timestamp":1765396609948,"version":"3.46.0"},"reference-count":18,"publisher":"Elsevier BV","issue":"5-6","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vascular Diseases"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.vasdi.2025.09.001","type":"journal-article","created":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T10:50:51Z","timestamp":1758711051000},"page":"162-165","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Thrombotic storm with paradoxical embolism in ovarian clear cell carcinoma"],"prefix":"10.1016","volume":"50","author":[{"given":"Elena-Mihaela","family":"Cordeanu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Corina","family":"Mirea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sol\u00e8ne","family":"Brouder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camille","family":"Zamperini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivier","family":"Ploncard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominique","family":"Stephan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vasdi.2025.09.001_bib0095","doi-asserted-by":"crossref","first-page":"2374716","DOI":"10.1155\/2020\/2374716","article-title":"Meta-analysis of VTE risk: ovarian cancer patients by stage, histology, cytoreduction, and ascites at diagnosis","volume":"2020","author":"Weeks","year":"2020","journal-title":"Obstet Gynecol Int"},{"key":"10.1016\/j.vasdi.2025.09.001_bib0100","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1001\/jama.293.6.715","article-title":"Malignancies, prothrombotic mutations, and the risk of venous thrombosis","volume":"293","author":"Blom","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.vasdi.2025.09.001_bib0105","doi-asserted-by":"crossref","first-page":"e1001275","DOI":"10.1371\/journal.pmed.1001275","article-title":"Risk of venous thromboembolism in patients with cancer: a systematic review and meta-analysis","volume":"9","author":"Horsted","year":"2012","journal-title":"PLoS Med"},{"key":"10.1016\/j.vasdi.2025.09.001_bib0110","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1055\/s-0044-1779672","article-title":"Risk of venous thromboembolism by cancer type: a network meta-analysis","volume":"50","author":"Betts","year":"2024","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.vasdi.2025.09.001_bib0115","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.3390\/cancers16112082","article-title":"Cancer-associated thrombosis: pathophysiology, laboratory assessment, and current guidelines","volume":"16","author":"Tsantes","year":"2024","journal-title":"Cancers"},{"key":"10.1016\/j.vasdi.2025.09.001_bib0120","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s12185-024-03735-x","article-title":"The pathogenesis of cancer-associated thrombosis","volume":"119","author":"Tatsumi","year":"2024","journal-title":"Int J Hematol"},{"key":"10.1016\/j.vasdi.2025.09.001_bib0125","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.amjmed.2010.10.018","article-title":"Thrombotic storm revisited: preliminary diagnostic criteria suggested by the thrombotic storm study group","volume":"124","author":"Kitchens","year":"2011","journal-title":"Am J Med"},{"key":"10.1016\/j.vasdi.2025.09.001_bib0130","first-page":"395879","article-title":"Thrombus in transit through patent foramen ovale","volume":"2013","author":"Baydoun","year":"2013","journal-title":"Case Rep Cardiol"},{"key":"10.1016\/j.vasdi.2025.09.001_bib0135","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1378\/chest.09-0961","article-title":"Impending paradoxical embolism: systematic review of prognostic factors and treatment","volume":"137","author":"Myers","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.vasdi.2025.09.001_bib0140","doi-asserted-by":"crossref","first-page":"9055","DOI":"10.3390\/ijms25169055","article-title":"The phenomenon of thrombotic microangiopathy in cancer patients","volume":"25","author":"Vorobev","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.vasdi.2025.09.001_bib0145","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3390\/antib5030018","article-title":"Antiphospholipid antibodies: from general concepts to its relation with malignancies","volume":"5","author":"G\u00f3mez-Puerta","year":"2016","journal-title":"Antibodies"},{"key":"10.1016\/j.vasdi.2025.09.001_bib0150","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1007\/s12185-024-03912-y","article-title":"Clinical practice guidelines for management of disseminated intravascular coagulation in Japan 2024. Part 3: solid cancers and vascular abnormalities","volume":"121","author":"Seki","year":"2025","journal-title":"Int J Hematol"},{"key":"10.1016\/j.vasdi.2025.09.001_bib0155","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1056\/NEJM199908193410807","article-title":"Disseminated intravascular coagulation","volume":"341","author":"Levi","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vasdi.2025.09.001_bib0160","doi-asserted-by":"crossref","first-page":"e013637","DOI":"10.1161\/CIRCINTERVENTIONS.123.013637","article-title":"Clinical outcomes and predictors of advanced therapy for the management of right heart thrombus","volume":"17","author":"Watson","year":"2024","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.vasdi.2025.09.001_bib0165","doi-asserted-by":"crossref","first-page":"e334","DOI":"10.1016\/S1470-2045(22)00160-7","article-title":"2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19","volume":"23","author":"Farge","year":"2022","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.vasdi.2025.09.001_bib0170","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.annonc.2022.12.014","article-title":"Venous thromboembolism in cancer patients: ESMO clinical practice guideline","volume":"34","author":"Falanga","year":"2023","journal-title":"Ann Oncol"},{"key":"10.1016\/j.vasdi.2025.09.001_bib0175","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/j.1538-7836.2009.03326.x","article-title":"Dose escalation of low molecular weight heparin to manage recurrent venous thromboembolic events despite systemic anticoagulation in cancer patients","volume":"7","author":"Carrier","year":"2009","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.vasdi.2025.09.001_bib0180","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1200\/JCO.19.01461","article-title":"Venous thromboembolism prophylaxis and treatment in patients with cancer: ASCO clinical practice guideline update","volume":"38","author":"Key","year":"2020","journal-title":"J Clin Oncol"}],"container-title":["Vascular Diseases"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S3050658125002560?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S3050658125002560?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T19:54:16Z","timestamp":1765396456000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S3050658125002560"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":18,"journal-issue":{"issue":"5-6","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S3050658125002560"],"URL":"https:\/\/doi.org\/10.1016\/j.vasdi.2025.09.001","relation":{},"ISSN":["3050-6581"],"issn-type":[{"type":"print","value":"3050-6581"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thrombotic storm with paradoxical embolism in ovarian clear cell carcinoma","name":"articletitle","label":"Article Title"},{"value":"Vascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vasdi.2025.09.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}